Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

The type 1 pili regulator gene fimX and pathogenicity island PAI-X as molecular markers of uropathogenic Escherichia coli.

Bateman SL, Stapleton AE, Stamm WE, Hooton TM, Seed PC.

Microbiology. 2013 Aug;159(Pt 8):1606-17. doi: 10.1099/mic.0.066472-0. Epub 2013 Jun 6.

2.

LeuX tRNA-dependent and -independent mechanisms of Escherichia coli pathogenesis in acute cystitis.

Hannan TJ, Mysorekar IU, Chen SL, Walker JN, Jones JM, Pinkner JS, Hultgren SJ, Seed PC.

Mol Microbiol. 2008 Jan;67(1):116-28. Epub 2007 Nov 25.

3.

Distribution of pathogenicity island markers in commensal and uropathogenic Escherichia coli isolates.

Samei A, Haghi F, Zeighami H.

Folia Microbiol (Praha). 2016 May;61(3):261-8. doi: 10.1007/s12223-015-0433-8. Epub 2015 Nov 12.

PMID:
26563230
4.

Pathogenicity island markers in commensal and uropathogenic Escherichia coli isolates.

Sabaté M, Moreno E, Pérez T, Andreu A, Prats G.

Clin Microbiol Infect. 2006 Sep;12(9):880-6.

5.

Evaluation of PAIusp subtyping to characterize uropathogenic E. coli isolates.

Lai YM, Zaw MT, Shamsudin SB, Lin Z.

J Infect Dev Ctries. 2016 Oct 31;10(10):1053-1058. doi: 10.3855/jidc.6944.

6.

Comparative proteomics of uropathogenic Escherichia coli during growth in human urine identify UCA-like (UCL) fimbriae as an adherence factor involved in biofilm formation and binding to uroepithelial cells.

Wurpel DJ, Totsika M, Allsopp LP, Webb RI, Moriel DG, Schembri MA.

J Proteomics. 2016 Jan 10;131:177-89. doi: 10.1016/j.jprot.2015.11.001. Epub 2015 Nov 3.

7.

Regulation of type 1 fimbriae by unlinked FimB- and FimE-like recombinases in uropathogenic Escherichia coli strain CFT073.

Bryan A, Roesch P, Davis L, Moritz R, Pellett S, Welch RA.

Infect Immun. 2006 Feb;74(2):1072-83.

8.

Polymerase chain reaction-restriction fragment length polymorphism method for differentiation of uropathogenic specific protein gene types.

Lai YM, Zaw MT, Shamsudin SB, Lin Z.

J Microbiol Immunol Infect. 2016 Aug;49(4):591-4. doi: 10.1016/j.jmii.2015.06.002. Epub 2015 Jun 27.

9.

Molecular Characterization of the Vacuolating Autotransporter Toxin in Uropathogenic Escherichia coli.

Nichols KB, Totsika M, Moriel DG, Lo AW, Yang J, Wurpel DJ, Rossiter AE, Strugnell RA, Henderson IR, Ulett GC, Beatson SA, Schembri MA.

J Bacteriol. 2016 Apr 28;198(10):1487-98. doi: 10.1128/JB.00791-15. Print 2016 May 15.

10.

FNR regulates expression of important virulence factors contributing to pathogenicity of uropathogenic Escherichia coli.

Barbieri NL, Nicholson B, Hussein A, Cai W, Wannemuehler YM, Dell'Anna G, Logue CM, Horn F, Nolan LK, Li G.

Infect Immun. 2014 Dec;82(12):5086-98. doi: 10.1128/IAI.02315-14. Epub 2014 Sep 22.

11.

Distinguishing the contribution of type 1 pili from that of other QseB-misregulated factors when QseC is absent during urinary tract infection.

Kostakioti M, Hadjifrangiskou M, Cusumano CK, Hannan TJ, Janetka JW, Hultgren SJ.

Infect Immun. 2012 Aug;80(8):2826-34. doi: 10.1128/IAI.00283-12. Epub 2012 Jun 4.

12.

Lower prevalence of hlyD, papC and cnf-1 genes in ciprofloxacin-resistant uropathogenic Escherichia coli than their susceptible counterparts isolated from southern India.

Harwalkar A, Gupta S, Rao A, Srinivasa H.

J Infect Public Health. 2014 Sep-Oct;7(5):413-9. doi: 10.1016/j.jiph.2014.04.002. Epub 2014 May 23.

13.

F9 fimbriae of uropathogenic Escherichia coli are expressed at low temperature and recognise Galβ1-3GlcNAc-containing glycans.

Wurpel DJ, Totsika M, Allsopp LP, Hartley-Tassell LE, Day CJ, Peters KM, Sarkar S, Ulett GC, Yang J, Tiralongo J, Strugnell RA, Jennings MP, Schembri MA.

PLoS One. 2014 Mar 26;9(3):e93177. doi: 10.1371/journal.pone.0093177. eCollection 2014.

14.

Decreased expression of type 1 fimbriae by a pst mutant of uropathogenic Escherichia coli reduces urinary tract infection.

Crépin S, Houle S, Charbonneau MÈ, Mourez M, Harel J, Dozois CM.

Infect Immun. 2012 Aug;80(8):2802-15. doi: 10.1128/IAI.00162-12. Epub 2012 Jun 4.

15.

MOLECULAR CHARACTERIZATION OF VIRULENCE AND ANTIMICROBIAL SUSCEPTIBILITY PROFILES OF UROPATHOGENIC ESCHERICHIA COLI FROM PATIENTS IN A TERTIARY HOSPITAL, SOUTHERN THAILAND.

Themphachanal M, Kongpheng S, Rattanachuay P, Khianngam S, Singkhamanan K, Sukhumungoon P.

Southeast Asian J Trop Med Public Health. 2015 Nov;46(6):1021-30.

PMID:
26867360
16.

Virulence factors of uropathogenic Escherichia coli of urinary tract infections and asymptomatic bacteriuria in children.

Yun KW, Kim HY, Park HK, Kim W, Lim IS.

J Microbiol Immunol Infect. 2014 Dec;47(6):455-61. doi: 10.1016/j.jmii.2013.07.010. Epub 2013 Sep 21.

17.

Virulence factors of uropathogenic E. coli and their interaction with the host.

Lüthje P, Brauner A.

Adv Microb Physiol. 2014;65:337-72. doi: 10.1016/bs.ampbs.2014.08.006. Epub 2014 Nov 4. Review.

PMID:
25476769
18.

A novel two-component signaling system facilitates uropathogenic Escherichia coli's ability to exploit abundant host metabolites.

Cai W, Wannemuehler Y, Dell'anna G, Nicholson B, Barbieri NL, Kariyawasam S, Feng Y, Logue CM, Nolan LK, Li G.

PLoS Pathog. 2013;9(6):e1003428. doi: 10.1371/journal.ppat.1003428. Epub 2013 Jun 27.

19.

Production of the Escherichia coli common pilus by uropathogenic E. coli is associated with adherence to HeLa and HTB-4 cells and invasion of mouse bladder urothelium.

Saldaña Z, De la Cruz MA, Carrillo-Casas EM, Durán L, Zhang Y, Hernández-Castro R, Puente JL, Daaka Y, Girón JA.

PLoS One. 2014 Jul 18;9(7):e101200. doi: 10.1371/journal.pone.0101200. eCollection 2014.

20.

Interplay between pathogenicity island carriage, resistance profile and plasmid acquisition in uropathogenic Escherichia coli.

Calhau V, Domingues S, Ribeiro G, Mendonça N, Da Silva GJ.

J Med Microbiol. 2015 Aug;64(8):828-35. doi: 10.1099/jmm.0.000104.

PMID:
26293926

Supplemental Content

Support Center